Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clinton Medicare anti-fraud proposal will include civil money penalty amount for DME supplier violations.

This article was originally published in The Gray Sheet

Executive Summary

MEDICARE CIVIL MONEY PENALTIES FOR DME SUPPLIERS TO BE CLARIFIED under the Clinton Administration's Medicare and Medicaid anti-fraud legislative initiative. According to a bill summary released March 25, the proposal would correct "the statutory oversight which failed to specify a dollar amount for civil money penalties that may be imposed" in a number of Medicare or Medicaid fraud and abuse situations, including penalties against companies "who fail to supply durable medical equipment without charge after all the rental payments have been made."

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007776

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel